A comparison was made of the virulence in L'ivo and the infectivity in vitro for macrophages of (i) tissue culture-passed mouse cytomegalovirus (MCMV), (ii) salivary gland virus taken 3 weeks after infection (SGV 3w), and (iii) salivary gland virus taken 1 week after infection (SGV lw). Salivary gland virus (3w) is known to be coated with non-neutralizing antibody, and is more virulent for newborn suckling mice and less infectious for macrophages than tissue culture-passed virus (TCV). Properties of SGV lw were similar to those of TCV. Infectivity of SGV 3w for macrophages was significantly enhanced by treatment with trypsin (10 ~tg/ml) and at the same time virulence was lost. When SGV lw or TCV were treated with trypsin the infectivity for macrophages was unaltered as long as the inoculum was adjusted to contain the same number of p.f.u, as assayed in MEF. Trypsin-treated SGV 3w was neutralized not by rabbit anti-mouse IgG Fc, but by anti-Fab, whereas untreated virus was neutralized by both of these anti-mouse immunoglobulins. These results are discussed in terms of the association of virulence with virion-bound antibody and Fc receptors on macrophages.
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Macrophages are infected in acute mouse cytomegalovirus (MCMV) infection, and possibly play a key role in viral persistence (Selgrade & Osborn, 1974; Hudson et al., 1978; Mims & Gould, 1978; Brautigam et al., 1979; Mogensen, 1979) . In an earlier study of the role of macrophages in MCMV infection in mice (Mims & Gould, 1978) , we showed that resident mouse peritoneal macrophages were infected about 10 times less readily by salivary gland (virulent) virus than by tissue culture-passed (attenuated) virus. Although results from different laboratories have varied, perhaps because different strains of mice and different strains of virus were used, in at least two reports MCMV infected a minority of peritoneal macrophages, and virus yields were low (Mims & Gould, 1978 : Shanley & Pesanti, 1983 . We also observed that non-neutralizing antibodies are attached to salivary gland virus particles . We have therefore made a closer study of the effect of antiviral antibodies on the infectivity of MCMV for macrophages, and on the relation between antibodies bound to virus particles and virus virulence. The virulence of MCMV is lost or regained on single passage in cultured cells or in salivary glands and this is presumably due to phenotypic rather than genetic changes in the virus (Osborn & Walker, 1971 ; Eizuru & Minamishima, 1979; Selgrade et al., 1981 ; Jordan & Takagi, 1983) .
Strains of MCMV, virus assay method, strain of mice, macrophage culture method, preparation of anti-MCMV serum and fluorescent antibody (FA) methods are described in the accompanying paper (Inada et al., 1985) .
Peritoneal macrophages were infected with different doses of tissue culture-passed virus (TCV), or salivary gland virus (SGV) taken 1 week (SGV lw) or 3 weeks (SGV 3w) after infection and infected cell counts made 36 h later after fluorescent antibody staining. SGV 3w infected macrophages about 10 times less readily than TCV or SGV lw (data not shown). This could be due in part to the fact that in contrast to SGV lw and TCV, SGV 3w is coated with nonneutralizing antibody (Chong et al., 198 l) . Accordingly, the effect of trypsin treatment of SGV 0000-6316 © 1985 SGM Input virus/ring Virus yield from macrophagesll 6 x 10 -~ p.f.u. 2 × 104 p.f.u. 6 x 104 p.f.u. 84.8 +_ 4.5 § 1465"0 + 112.3 288-3 ± 18"2 247.8 ± 18"8 1613"8 ± 105'3 1453.5 ± 159'2 6 x 10 -~ p.f.u. 2 x 10 "~ p.f.u. 6 x 10 -~ p.f.u. 22.2 + 1.8 § 229.8 ± 18.8 54.3 ± 2.5 48.5 ± 4-1 228.5 ± 7.0 260.3 ± 11.5 * Several MCMV preparations, diluted 30-to 100-fold, were treated with trypsin (10 gg/ml) at 37 °C for 20 min, then cooled on ice, 10°.o newborn calf serum was added to stop trypsin activity, and their infectivity was assayed on MEF and macrophages.
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was investigated. As shown in Table 1 , treatment ofSGV 3w with trypsin (10 txg/ml) (Cambrian Chemicals, Croydon, U.K.) enhanced its infectivity about twofold on mouse embryo fibroblasts (MEF), whereas this treatment significantly inactivated SGV lw and caused much greater inactivation of TCV. The fall in infectivity of trypsin-treated TCV for MEF is perhaps a reflection of the greater fragility of the multicapsid virions that are responsible for infectivity in these preparations . Treatment with a higher concentration (100 gg/ml) of trypsin inactivated all virus preparations. Infectivity for macrophages was also tested, adjusting the inoculum of the trypsin-treated virus preparations so that the same number of p.f.u, were added as for untreated virus. SGV 3w virus infectivity for macrophages was greatly enhanced by trypsin treatment as seen by fluorescence staining and by assaying virus recovered from cultures, but trypsin treatment had no significant effect on TCV and SGV lw infectivity for macrophages. The virions of SGV 3w are coated with non-neutralizing antibodies , and experiments were done to determine whether trypsin treatment removes these antibodies. Virus preparations were mixed and incubated with appropriately diluted rabbit antibody to mouse IgG Fc or IgG Fab fragment (Nordic Immunological Laboratories, Maidenhead, U.K.) for 1 h at 37 °C, and aliquots were diluted and assayed for infectivity on MEF. As shown in Table 2 , TCV and SGV lw were not neutralized by anti-mouse globulins at any dilution. SGV 3w was neutralized by both anti-mouse IgG Fc and anti-Fab antibody diluted up to 1/10. Trypsin-treated SGV 3w was, however, no longer neutralized by anti-Fc, but still neutralized by anti-Fab. These results indicate that treatment of virus with trypsin specifically removed the Fc portion of IgG bound to virus particles. Trypsin-treated SGV 3w also showed a small, but significant, increase in infectivity on MEF. This might be accounted for by assuming that MEF contain a small number of macrophages or Fc receptor-bearing cells. We have observed that 5 to 10% of cells in primary mouse embryo cell cultures are stainable by monoclonal anti-mouse macrophage antibody F4/80 (unpublished observations), kindly provided by Dr S. Gordon.
MCMV virulence was determined from mortality following intraperitoneal infection of 5-day-old mice with 103 and 5 x 103 p.f.u, virus. Mice were observed for 14 days after infection. The results (Table 3) show that SGV 3w is more virulent than SGV lw, which in turn is slightly more virulent than TCV. Trypsin treatment ofSGV 3w reduced its virulence to the same level as that of SGV lw. These results indicate that there is an inverse correlation between MCMV virulence and its infectivity for peritoneal macrophages.
